FDA Inspection
ATSF NE OfficeATSF NE Office – FDA Inspection, Dec 18, 2014
Record Details
This FDA Inspection record concerns ATSF NE Office, with an inspection on December 18, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- ATSF NE Office
- Inspection Date
- December 18, 2014
- Product Type
- Biologics
View Company Profile
ID · d5b0d5c2-0628-4a85-bdae-10de4852d8e3
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 908387
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of ATSF NE Office
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 21, 2026 | Not classified | Minneapolis District Office | |
| May 4, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| March 7, 2017 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for ATSF NE Office
- FDA Inspection 1318880 - 2026-04-21
- FDA Inspection 1170922 - 2022-05-04
- FDA Inspection 1017531 - 2017-03-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.